andrew_gelman_stats andrew_gelman_stats-2014 andrew_gelman_stats-2014-2316 knowledge-graph by maker-knowledge-mining

2316 andrew gelman stats-2014-05-03-“The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)”


meta infos for this blog

Source: html

Introduction: Paul Alper writes: You recently posted on graphs and how to convey information.  I don’t believe you have ever posted anything on this dynamite randomized clinical trial of 90,000 (!!) 40-59 year-old women over a 25-year period (also !!). The graphs below are figures 2, 3 and 4 respectively, of http://www.bmj.com/content/348/bmj.g366 The control was physical exam only and the treatment was physical exam plus mammography. The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment).  Note the superfluousness of the p-values.    There is an accompanying editorial in the BMJ http://www.bmj.com/content/348/bmj.g1403 which refers to “vested interests” which can override any statistics, no matter how striking: We agree with Miller and colleagues that “the rationale for screening by mammography be urgently reassessed by policy makers.” As time goes


Summary: the most important sentenses genereted by tfidf model

sentIndex sentText sentNum sentScore

1 Paul Alper writes: You recently posted on graphs and how to convey information. [sent-1, score-0.227]

2 I don’t believe you have ever posted anything on this dynamite randomized clinical trial of 90,000 (! [sent-2, score-0.315]

3 The graphs below are figures 2, 3 and 4 respectively, of http://www. [sent-7, score-0.076]

4 g366 The control was physical exam only and the treatment was physical exam plus mammography. [sent-10, score-0.827]

5 The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment). [sent-11, score-0.963]

6 There is an accompanying editorial in the BMJ http://www. [sent-13, score-0.155]

7 g1403 which refers to “vested interests” which can override any statistics, no matter how striking: We agree with Miller and colleagues that “the rationale for screening by mammography be urgently reassessed by policy makers. [sent-16, score-1.08]

8 ” As time goes by we do indeed need more efficient mechanisms to reconsider priorities and recommendations for mammography screening and other medical interventions. [sent-17, score-1.278]

9 This is not an easy task, because governments, research funders, scientists, and medical practitioners may have vested interests in continuing activities that are well established. [sent-18, score-0.573]

10 And for the aging males in your audience: Nevertheless, the UK National Screening Committee does recommend mammography screening for breast cancer but not prostate specific antigen screening for prostate cancer. [sent-19, score-2.364]

11 Because the scientific rationale to recommend screening or not does not differ noticeably between breast and prostate cancer, political pressure and beliefs might have a role. [sent-20, score-1.388]

12 Although I guess the point is that a thorough physical exam won’t miss much. [sent-23, score-0.513]


similar blogs computed by tfidf model

tfidf for this blog:

wordName wordTfidf (topN-words)

[('screening', 0.47), ('mammography', 0.389), ('prostate', 0.292), ('vested', 0.227), ('exam', 0.211), ('breast', 0.163), ('rationale', 0.159), ('physical', 0.159), ('survival', 0.146), ('cancer', 0.118), ('interests', 0.114), ('reconsider', 0.103), ('funders', 0.097), ('dynamite', 0.097), ('medical', 0.095), ('http', 0.093), ('posted', 0.09), ('noticeably', 0.09), ('recommend', 0.09), ('treatment', 0.087), ('alper', 0.085), ('priorities', 0.083), ('accompanying', 0.083), ('governments', 0.081), ('uk', 0.081), ('males', 0.08), ('respectively', 0.078), ('mechanisms', 0.078), ('miller', 0.077), ('graphs', 0.076), ('unnecessary', 0.076), ('decreases', 0.075), ('thorough', 0.075), ('nevertheless', 0.074), ('editorial', 0.072), ('committee', 0.071), ('practitioners', 0.071), ('virtually', 0.07), ('miss', 0.068), ('activities', 0.066), ('believe', 0.065), ('striking', 0.064), ('trial', 0.063), ('pressure', 0.063), ('refers', 0.062), ('convey', 0.061), ('beliefs', 0.061), ('task', 0.061), ('adds', 0.061), ('recommendations', 0.06)]

similar blogs list:

simIndex simValue blogId blogTitle

same-blog 1 0.99999994 2316 andrew gelman stats-2014-05-03-“The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)”

Introduction: Paul Alper writes: You recently posted on graphs and how to convey information.  I don’t believe you have ever posted anything on this dynamite randomized clinical trial of 90,000 (!!) 40-59 year-old women over a 25-year period (also !!). The graphs below are figures 2, 3 and 4 respectively, of http://www.bmj.com/content/348/bmj.g366 The control was physical exam only and the treatment was physical exam plus mammography. The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment).  Note the superfluousness of the p-values.    There is an accompanying editorial in the BMJ http://www.bmj.com/content/348/bmj.g1403 which refers to “vested interests” which can override any statistics, no matter how striking: We agree with Miller and colleagues that “the rationale for screening by mammography be urgently reassessed by policy makers.” As time goes

2 0.21202378 1455 andrew gelman stats-2012-08-12-Probabilistic screening to get an approximate self-weighted sample

Introduction: Sharad had a survey sampling question: We’re trying to use mechanical turk to conduct some surveys, and have quickly discovered that turkers tend to be quite young. We’d really like a representative sample of the U.S., or at the least be able to recruit a diverse enough sample from turk that we can post-stratify to adjust the estimates. The approach we ended up taking is to pay turkers a small amount to answer a couple of screening questions (age & sex), and then probabilistically recruit individuals to complete the full survey (for more money) based on the estimated turk population parameters and our desired target distribution. We use rejection sampling, so the end result is that individuals who are invited to take the full survey look as if they came from a representative sample, at least in terms of age and sex. I’m wondering whether this sort of technique—a two step design in which participants are first screened and then probabilistically selected to mimic a target distributio

3 0.19699472 2310 andrew gelman stats-2014-04-28-On deck this week

Introduction: Mon : Crowdstorming a dataset Tues : Ken Rice presents a unifying approach to statistical inference and hypothesis testing Wed : The health policy innovation center: how best to move from pilot studies to large-scale practice? Thurs : Heller, Heller, and Gorfine on univariate and multivariate information measures Fri : Discovering general multidimensional associations Sat : “The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)” Sun : Honored oldsters write about statistics

4 0.14594707 2205 andrew gelman stats-2014-02-10-More on US health care overkill

Introduction: Paul Alper writes: You recently posted my moving and widening the goalposts contention. In it, I mentioned “how diagnoses increase markedly while deaths are flatlined” indicating that we are being overdiagnosed and overtreated. Above are 5 frightening graphs which illustrate the phenomenon. Defenders of the system might (ludicrously) contend that it is precisely the aggressive medical care that is responsible for keeping the cancers under control. The prostate cancer graph is particularly interesting because it shows the peaking of the PSA-driven cause of treatment in the 1990s which then falls off as the evidence accumulates that the PSA was far from a perfect indicator. In contrast is the thyroid cancer which zooms skyward even as the death rate is absolutely (dead) flat. And of course here’s the famous cross-country comparison that some find “ schlocky ” but which I (and many others) find compelling :

5 0.13433373 2312 andrew gelman stats-2014-04-29-Ken Rice presents a unifying approach to statistical inference and hypothesis testing

Introduction: Ken Rice writes: In the recent discussion on stopping rules I saw a comment that I wanted to chip in on, but thought it might get a bit lost, in the already long thread. Apologies in advance if I misinterpreted what you wrote, or am trying to tell you things you already know. The comment was: “In Bayesian decision making, there is a utility function and you choose the decision with highest expected utility. Making a decision based on statistical significance does not correspond to any utility function.” … which immediately suggests this little 2010 paper; A Decision-Theoretic Formulation of Fisher’s Approach to Testing, The American Statistician, 64(4) 345-349. It contains utilities that lead to decisions that very closely mimic classical Wald tests, and provides a rationale for why this utility is not totally unconnected from how some scientists think. Some (old) slides discussing it are here . A few notes, on things not in the paper: * I know you don’t like squared-

6 0.12666886 21 andrew gelman stats-2010-05-07-Environmentally induced cancer “grossly underestimated”? Doubtful.

7 0.10634794 2264 andrew gelman stats-2014-03-24-On deck this month

8 0.098425016 308 andrew gelman stats-2010-09-30-Nano-project qualifying exam process: An intensified dialogue between students and faculty

9 0.094801188 2175 andrew gelman stats-2014-01-18-A course in sample surveys for political science

10 0.092380121 1766 andrew gelman stats-2013-03-16-“Nightshifts Linked to Increased Risk for Ovarian Cancer”

11 0.091619529 383 andrew gelman stats-2010-10-31-Analyzing the entire population rather than a sample

12 0.090297818 1906 andrew gelman stats-2013-06-19-“Behind a cancer-treatment firm’s rosy survival claims”

13 0.086107366 85 andrew gelman stats-2010-06-14-Prior distribution for design effects

14 0.076365873 1311 andrew gelman stats-2012-05-10-My final exam for Design and Analysis of Sample Surveys

15 0.071056142 2347 andrew gelman stats-2014-05-25-Why I decided not to be a physicist

16 0.068738066 2120 andrew gelman stats-2013-12-02-Does a professor’s intervention in online discussions have the effect of prolonging discussion or cutting it off?

17 0.066758066 2199 andrew gelman stats-2014-02-04-Widening the goalposts in medical trials

18 0.063207865 994 andrew gelman stats-2011-11-06-Josh Tenenbaum presents . . . a model of folk physics!

19 0.061660886 613 andrew gelman stats-2011-03-15-Gay-married state senator shot down gay marriage

20 0.059643108 399 andrew gelman stats-2010-11-07-Challenges of experimental design; also another rant on the practice of mentioning the publication of an article but not naming its author


similar blogs computed by lsi model

lsi for this blog:

topicId topicWeight

[(0, 0.083), (1, -0.028), (2, 0.004), (3, -0.028), (4, 0.019), (5, -0.019), (6, -0.036), (7, 0.011), (8, -0.009), (9, 0.008), (10, -0.023), (11, 0.006), (12, 0.037), (13, 0.02), (14, 0.011), (15, -0.004), (16, 0.011), (17, -0.005), (18, 0.005), (19, 0.011), (20, -0.004), (21, 0.03), (22, -0.025), (23, 0.014), (24, -0.007), (25, 0.036), (26, -0.015), (27, 0.012), (28, 0.004), (29, 0.03), (30, -0.026), (31, 0.008), (32, -0.014), (33, 0.027), (34, -0.007), (35, -0.042), (36, -0.0), (37, -0.039), (38, 0.013), (39, 0.001), (40, -0.01), (41, -0.046), (42, 0.039), (43, -0.001), (44, 0.02), (45, 0.009), (46, 0.042), (47, 0.01), (48, -0.049), (49, 0.036)]

similar blogs list:

simIndex simValue blogId blogTitle

same-blog 1 0.96003622 2316 andrew gelman stats-2014-05-03-“The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)”

Introduction: Paul Alper writes: You recently posted on graphs and how to convey information.  I don’t believe you have ever posted anything on this dynamite randomized clinical trial of 90,000 (!!) 40-59 year-old women over a 25-year period (also !!). The graphs below are figures 2, 3 and 4 respectively, of http://www.bmj.com/content/348/bmj.g366 The control was physical exam only and the treatment was physical exam plus mammography. The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment).  Note the superfluousness of the p-values.    There is an accompanying editorial in the BMJ http://www.bmj.com/content/348/bmj.g1403 which refers to “vested interests” which can override any statistics, no matter how striking: We agree with Miller and colleagues that “the rationale for screening by mammography be urgently reassessed by policy makers.” As time goes

2 0.77378273 2205 andrew gelman stats-2014-02-10-More on US health care overkill

Introduction: Paul Alper writes: You recently posted my moving and widening the goalposts contention. In it, I mentioned “how diagnoses increase markedly while deaths are flatlined” indicating that we are being overdiagnosed and overtreated. Above are 5 frightening graphs which illustrate the phenomenon. Defenders of the system might (ludicrously) contend that it is precisely the aggressive medical care that is responsible for keeping the cancers under control. The prostate cancer graph is particularly interesting because it shows the peaking of the PSA-driven cause of treatment in the 1990s which then falls off as the evidence accumulates that the PSA was far from a perfect indicator. In contrast is the thyroid cancer which zooms skyward even as the death rate is absolutely (dead) flat. And of course here’s the famous cross-country comparison that some find “ schlocky ” but which I (and many others) find compelling :

3 0.63364983 21 andrew gelman stats-2010-05-07-Environmentally induced cancer “grossly underestimated”? Doubtful.

Introduction: The (U.S.) “President’s Cancer Panel” has released its 2008-2009 annual report, which includes a cover letter that says “the true burden of environmentally induced cancer has been grossly underestimated.” The report itself discusses exposures to various types of industrial chemicals, some of which are known carcinogens, in some detail, but gives nearly no data or analysis to suggest that these exposures are contributing to significant numbers of cancers. In fact, there is pretty good evidence that they are not. The plot above shows age-adjusted cancer mortality for men, by cancer type, in the U.S. The plot below shows the same for women. In both cases, the cancers with the highest mortality rates are shown, but not all cancers (e.g. brain cancer is not shown). For what it’s worth, I’m not sure how trustworthy the rates are from the 1930s — it seems possible that reporting, autopsies, or both, were less careful during the Great Depression — so I suggest focusing on the r

4 0.62271661 947 andrew gelman stats-2011-10-08-GiveWell sez: Cost-effectiveness of de-worming was overstated by a factor of 100 (!) due to a series of sloppy calculations

Introduction: Alexander at GiveWell writes : The Disease Control Priorities in Developing Countries (DCP2), a major report funded by the Gates Foundation . . . provides an estimate of $3.41 per disability-adjusted life-year (DALY) for the cost-effectiveness of soil-transmitted-helminth (STH) treatment, implying that STH treatment is one of the most cost-effective interventions for global health. In investigating this figure, we have corresponded, over a period of months, with six scholars who had been directly or indirectly involved in the production of the estimate. Eventually, we were able to obtain the spreadsheet that was used to generate the $3.41/DALY estimate. That spreadsheet contains five separate errors that, when corrected, shift the estimated cost effectiveness of deworming from $3.41 to $326.43. [I think they mean to say $300 -- ed.] We came to this conclusion a year after learning that the DCP2’s published cost-effectiveness estimate for schistosomiasis treatment – another kind of

5 0.62120879 1741 andrew gelman stats-2013-02-27-Thin scientists say it’s unhealthy to be fat

Introduction: “Even as you get near the upper reaches of the normal weight range, you begin to see increases in chronic diseases,” said JoAnn Manson, chief of the Division of Preventive Medicine, Brigham and Women’s Hospital, HMS Michael and Lee Bell Professor of Women’s Health, and HSPH professor of epidemiology. “It’s a clear gradient of increase.” Yeah, she would say that. Thin people. And then there’s Frank Hu, professor of nutrition at Harvard: The studies that Flegal [the author of the original study finding a negative correlation between body mass index and mortality] did use included many samples of people who were chronically ill, current smokers and elderly, according to Hu. These factors are associated with weight loss and increased mortality. In other words, people are not dying because they are slim, he said. They are slim because they are dying—of cancer or old age, for example. By doing a meta-analysis of studies that did not properly control for this bias, Flegal amplif

6 0.61327261 1524 andrew gelman stats-2012-10-07-An (impressive) increase in survival rate from 50% to 60% corresponds to an R-squared of (only) 1%. Counterintuitive, huh?

7 0.61147738 284 andrew gelman stats-2010-09-18-Continuing efforts to justify false “death panels” claim

8 0.61137837 463 andrew gelman stats-2010-12-11-Compare p-values from privately funded medical trials to those in publicly funded research?

9 0.611027 1906 andrew gelman stats-2013-06-19-“Behind a cancer-treatment firm’s rosy survival claims”

10 0.60640579 660 andrew gelman stats-2011-04-14-Job opening at NIH for an experienced statistician

11 0.60385615 1364 andrew gelman stats-2012-06-04-Massive confusion about a study that purports to show that exercise may increase heart risk

12 0.59020299 2328 andrew gelman stats-2014-05-10-What property is important in a risk prediction model? Discrimination or calibration?

13 0.58483642 411 andrew gelman stats-2010-11-13-Ethical concerns in medical trials

14 0.58449006 2199 andrew gelman stats-2014-02-04-Widening the goalposts in medical trials

15 0.58348566 2022 andrew gelman stats-2013-09-13-You heard it here first: Intense exercise can suppress appetite

16 0.57953525 287 andrew gelman stats-2010-09-20-Paul Rosenbaum on those annoying pre-treatment variables that are sort-of instruments and sort-of covariates

17 0.57803082 1239 andrew gelman stats-2012-04-01-A randomized trial of the set-point diet

18 0.57637066 1669 andrew gelman stats-2013-01-12-The power of the puzzlegraph

19 0.57521379 399 andrew gelman stats-2010-11-07-Challenges of experimental design; also another rant on the practice of mentioning the publication of an article but not naming its author

20 0.56662935 86 andrew gelman stats-2010-06-14-“Too much data”?


similar blogs computed by lda model

lda for this blog:

topicId topicWeight

[(2, 0.024), (6, 0.173), (7, 0.01), (13, 0.019), (16, 0.036), (24, 0.215), (27, 0.021), (47, 0.044), (57, 0.011), (59, 0.01), (61, 0.02), (63, 0.056), (76, 0.011), (81, 0.012), (91, 0.016), (95, 0.04), (99, 0.173)]

similar blogs list:

simIndex simValue blogId blogTitle

same-blog 1 0.95334172 2316 andrew gelman stats-2014-05-03-“The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)”

Introduction: Paul Alper writes: You recently posted on graphs and how to convey information.  I don’t believe you have ever posted anything on this dynamite randomized clinical trial of 90,000 (!!) 40-59 year-old women over a 25-year period (also !!). The graphs below are figures 2, 3 and 4 respectively, of http://www.bmj.com/content/348/bmj.g366 The control was physical exam only and the treatment was physical exam plus mammography. The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment).  Note the superfluousness of the p-values.    There is an accompanying editorial in the BMJ http://www.bmj.com/content/348/bmj.g1403 which refers to “vested interests” which can override any statistics, no matter how striking: We agree with Miller and colleagues that “the rationale for screening by mammography be urgently reassessed by policy makers.” As time goes

2 0.89194262 650 andrew gelman stats-2011-04-05-Monitor the efficiency of your Markov chain sampler using expected squared jumped distance!

Introduction: Marc Tanguay writes in with a specific question that has a very general answer. First, the question: I [Tanguay] am currently running a MCMC for which I have 3 parameters that are restricted to a specific space. 2 are bounded between 0 and 1 while the third is binary and updated by a Beta-Binomial. Since my priors are also bounded, I notice that, conditional on All the rest (which covers both data and other parameters), the density was not varying a lot within the space of the parameters. As a result, the acceptance rate is high, about 85%, and this despite the fact that all the parameter’s space is explore. Since in your book, the optimal acceptance rates prescribed are lower that 50% (in case of multiple parameters), do you think I should worry about getting 85%. Or is this normal given the restrictions on the parameters? First off: Yes, my guess is that you should be taking bigger jumps. 85% seems like too high an acceptance rate for Metropolis jumping. More generally, t

3 0.87503016 2310 andrew gelman stats-2014-04-28-On deck this week

Introduction: Mon : Crowdstorming a dataset Tues : Ken Rice presents a unifying approach to statistical inference and hypothesis testing Wed : The health policy innovation center: how best to move from pilot studies to large-scale practice? Thurs : Heller, Heller, and Gorfine on univariate and multivariate information measures Fri : Discovering general multidimensional associations Sat : “The graph clearly shows that mammography adds virtually nothing to survival and if anything, decreases survival (and increases cost and provides unnecessary treatment)” Sun : Honored oldsters write about statistics

4 0.84687555 221 andrew gelman stats-2010-08-21-Busted!

Introduction: I’m just glad that universities don’t sanction professors for publishing false theorems. If the guy really is nailed by the feds for fraud, I hope they don’t throw him in prison. In general, prison time seems like a brutal, expensive, and inefficient way to punish people. I’d prefer if the government just took 95% of his salary for several years, made him do community service (cleaning equipment at the local sewage treatment plant, perhaps; a lab scientist should be good at this sort of thing, no?), etc. If restriction of this dude’s personal freedom is judged be part of the sentence, he could be given some sort of electronic tag that would send a message to the police if he were ever more than 3 miles from his home. But no need to bill the taxpayers for the cost of keeping him in prison.

5 0.84538871 1576 andrew gelman stats-2012-11-13-Stan at NIPS 2012 Workshop on Probabilistic Programming

Introduction: If you need an excuse to go skiing in Tahoe next month, our paper on Stan as a probabilistic programming language was accepted for: Workshop on Probabilistic Programming NIPS 2012 7–8 December, 2012, Lake Tahoe, Nevada The workshop is organized by the folks behind the probabilistic programming language Church and has a great lineup of invited speakers (Chris Bishop, Josh Tennenbaum, and Stuart Russell). And in case you’re interested in the main conference, here’s the list of accepted NIPS 2012 papers and posters . To learn more about Stan, check out the links to the manual on the Stan Home Page We’ll put up a link to our final NIPS workshop paper there when we finish it.

6 0.83778948 1710 andrew gelman stats-2013-02-06-The new Stan 1.1.1, featuring Gaussian processes!

7 0.82517648 1258 andrew gelman stats-2012-04-10-Why display 6 years instead of 30?

8 0.82315409 1787 andrew gelman stats-2013-04-04-Wanna be the next Tyler Cowen? It’s not as easy as you might think!

9 0.81924772 1293 andrew gelman stats-2012-05-01-Huff the Magic Dragon

10 0.81755406 197 andrew gelman stats-2010-08-10-The last great essayist?

11 0.81638151 1455 andrew gelman stats-2012-08-12-Probabilistic screening to get an approximate self-weighted sample

12 0.81363863 1978 andrew gelman stats-2013-08-12-Fixing the race, ethnicity, and national origin questions on the U.S. Census

13 0.81331414 743 andrew gelman stats-2011-06-03-An argument that can’t possibly make sense

14 0.81249696 278 andrew gelman stats-2010-09-15-Advice that might make sense for individuals but is negative-sum overall

15 0.81244355 2143 andrew gelman stats-2013-12-22-The kluges of today are the textbook solutions of tomorrow.

16 0.81214619 1376 andrew gelman stats-2012-06-12-Simple graph WIN: the example of birthday frequencies

17 0.81204438 1479 andrew gelman stats-2012-09-01-Mothers and Moms

18 0.81102729 1999 andrew gelman stats-2013-08-27-Bayesian model averaging or fitting a larger model

19 0.81051362 482 andrew gelman stats-2010-12-23-Capitalism as a form of voluntarism

20 0.81019962 1092 andrew gelman stats-2011-12-29-More by Berger and me on weakly informative priors